This clinical trial will help us learn more about how to best care for babies with Neonatal Opioid Withdrawal Syndrome, also called NOWS. Babies with NOWS often have tremors, a hard time sleeping, excessive crying, and trouble feeding. Some babies that have NOWS need medicine. Doctors have two ways of providing medicine that are widely used today: 1. Scheduled opioid taper approach. The baby gets medicine at regular times. As symptoms get better, the amount of medicine the baby gets decreases until the baby no longer needs medicine. This is called a medicine taper. 2. Symptom-based approach. The baby will only get medicine when they show signs of NOWS, instead of at regular times. If the baby is showing no signs of NOWS, no medicine will be given. We are doing the OPTimize NOW study to figure out the best way to give medicine to babies with NOWS.
This two-period cluster crossover clinical trial will compare the length of time from birth until medically ready for discharge between infants with neonatal opioid withdrawal syndrome (NOWS) who are ≥ 36 weeks' gestation, at risk for pharmacologic treatment, and treated for NOWS with either a symptom-based dosing approach or a scheduled opioid taper approach. Each study site (i.e., cluster) will be randomized in a 1:1 allocation ratio to one of two sequences: * A three-week run-in period followed by a scheduled opioid taper approach for five months (Period 1) followed by a three-week washout period followed by a symptom-based dosing approach for five months (Period 2) * A three-week run-in period followed by a symptom-based dosing approach for five months (Period 1) followed by a three-week washout period followed by scheduled opioid taper approach for five months (Period 2) The randomization scheme will be stratified by the assessment and management approach used at each study site (i.e., Finnegan or Eat, Seep and Console).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
480
During this approach to care, all enrolled infants with NOWS at the study site will be treated with the symptom-based dosing approach if they meet the withdrawal threshold for pharmacologic treatment. Participants may receive up to 3 doses of the study site's preferred opioid during a 24-hour period to treat signs of withdrawal once the threshold for pharmacologic intervention is met. If a 4th dose is required within a 24-hour period, the study site will transition to the scheduled opioid taper algorithm used at the study site to complete the infant's pharmacologic treatment.
During this approach to care, all enrolled infants with NOWS at the study site will be treated with the study site's usual scheduled opioid taper approach, as detailed in each site's treatment algorithm, if they meet the withdrawal threshold for pharmacologic treatment.
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
ChristianaCare
Wilmington, Delaware, United States
University of South Florida Health
Tampa, Florida, United States
Sidney & Lois Eskenazi Hospital
Indianapolis, Indiana, United States
University of Louisville Hospital
Jeffersonville, Indiana, United States
University of Kansas Hospital
Kansas City, Kansas, United States
St. Elizabeth Healthcare
Edgewood, Kentucky, United States
Kentucky Children's Hospital
Lexington, Kentucky, United States
Norton Children's Hospital
Louisville, Kentucky, United States
...and 13 more locations
Time from birth until medically ready for discharge
Time from birth until infant meets criteria for medically ready for discharge (days). An infant is considered medically ready for discharge when they are discharged by the medical provider or when they meet the following criteria the following criteria: * ≥ 96 hours of age * ≥ 48 hours since last dose of opioid treatment (i.e., morphine, methadone, or buprenorphine)
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Receipt of pharmacologic treatment
If the infant received opioid replacement therapy prior to hospital discharge.
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Length of hospital stay
Number of days infant remained in the hospital
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Safety outcomes
Safety outcomes including presence or absence of inpatient seizures, excessive weight loss of more than 15% from birthweight, and non-accidental trauma and death, and outpatient acute/urgent care or emergency room visits, hospital readmissions, and non-accidental trauma and death
Time frame: From date of birth until 3 months of life
Total number opioid doses
The total number of opioid doses administered among all infants pharmacologically treated during initial hospitalization.
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Receipt of secondary medications
The total number of secondary opioid doses administered among all infants pharmacologically treated during intital hospitalization.
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Transition from treatment with a symptom-based dosing approach to a scheduled opioid taper approach
The total number of infants pharmacologically treated during intital hospitalization who transitioned from a symptom-based dosing approach to a scheduled opioid taper approach
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Stopped scheduled opioid taper treatment
The total number of infants pharmacologically treated during intital hospitalization who were initially treated with a scheduled opioid taper but stopped treatment due to excessive sedation or respiratory depression
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
Safety outcomes
Safety outcomes among infants pharmacologically treated during initial hospitalization including presence or absence of inpatient seizures, excessive weight loss of more than 15% from birthweight, and non-accidental trauma and death, and outpatient acute/urgent care or emergency room visits, hospital readmissions, and non-accidental trauma and death
Time frame: From date of birth until hospital discharge or 1 year, whichever comes first.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.